Project description
AI for communication assistance in cases of severe impairment
Degenerative neuromuscular diseases and ischemic or traumatic brain injuries cause paralysis and communication problems, with millions of patients worldwide being in a locked-in state or complete locked-in state (CLIS). Therefore, accessible and cost-effective solutions to help these patients communicate must be found. The Italian company LiquidWeb recently introduced the first medical device focussed on CLIS patients and based on artificial intelligence and wireless non-invasive sensors. The EU-funded BrainControl project is dedicated to the development of the horizontal multi-modal platform that allows the user to utilise the same interaction software despite disease progression, creating a truly adaptive interaction system for the specific needs of each patient by responding to the different degrees and types of impairments.
Objective
Degenerative neuromuscular diseases or ischemic or traumatic brain injuries can cause paralysis and communication
problems. Around 5 million of patients worldwide are in Locked-in State (LIS) or Complete LIS (CLIS).
The problem is therefore the actual difficulty of people with an intact cognitive ability but suffering from diseases that
completely or partially paralyze them, to find easy to use and cost-effective solutions to communicate with other people and
their environment that consequently help them to enhance their autonomy and quality of life.
The game changer solution is BrainControl. LiquidWeb, an Italian company founded in 2012, introduced into the market the
first BCI AAC medical device focused on CLIS patients: “BrainControl BCI AAC”. This MVP has demonstrated through
clinical pilots to be a game changer solution assisting CLIS patients thanks to its core technological core based on artificial
intelligence and EEG sensors (wireless, non-invasive).After this milestone, the company has been focused on the
development of the first horizontal multimodal platform in the assistive technologies market that lets the user utilize the same
solution and interaction software despite disease progression. BrainControl is indeed a truly personalized and adaptive
interaction system, meeting specific needs of each patient at any time by responding to the different degrees and types of
impairments. It can manage multiple biofeedback sensors: EEG (for BCI), wireless inertial sensors and cameras (for patterns
recognitions), etc.
The uniqueness: BrainControl brings a new era of personalized and adaptive human computer interaction -HCI- through
multimodal bio-feedback, achieving an extraordinary improvement of social inclusion & quality of life: Increasing autonomy,
reducing up to 30% the severity of anxiety and depression -measured following rating scales and questionnaires as HRS-D,
HRS-A, ALSAQ-40, MQOL- and getting a rate of satisfaction after using our solution of 75/100
Fields of science
Not validated
Not validated
- natural sciencescomputer and information sciencessoftware
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- natural sciencescomputer and information sciencesartificial intelligencepattern recognition
- medical and health sciencesbasic medicineneurology
Keywords
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
53100 Siena
Italy
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.